76 related articles for article (PubMed ID: 2937657)
1. Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate.
Fåhraeus L; Sydsjö A; Wallentin L
Fertil Steril; 1986 Apr; 45(4):503-6. PubMed ID: 2937657
[TBL] [Abstract][Full Text] [Related]
2. Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women.
Fåhraeus L; Larsson-Cohn U; Ljungberg S; Wallentin L
Fertil Steril; 1984 Jul; 42(1):52-7. PubMed ID: 6724013
[TBL] [Abstract][Full Text] [Related]
3. Lipid metabolic changes during hormonal treatment of endometriosis.
Teichmann AT; Cremer P; Wieland H; Kuhn W; Seidel D
Maturitas; 1988 May; 10(1):27-33. PubMed ID: 2969446
[TBL] [Abstract][Full Text] [Related]
4. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
5. Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis.
Telimaa S; Penttilä I; Puolakka J; Rönnberg L; Kauppila A
Fertil Steril; 1989 Jul; 52(1):31-5. PubMed ID: 2526031
[TBL] [Abstract][Full Text] [Related]
6. Medroxyprogesterone acetate and lipid metabolic changes.
Teichmann AT; Wander HE; Cremer P; Wieland H; Kuhn W; Nagel GA; Seidel D
Arzneimittelforschung; 1987 May; 37(5):573-7. PubMed ID: 2956958
[TBL] [Abstract][Full Text] [Related]
7. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Cedars MI; Lu JK; Meldrum DR; Judd HL
Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
[TBL] [Abstract][Full Text] [Related]
8. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis.
Telimaa S; Puolakka J; Rönnberg L; Kauppila A
Gynecol Endocrinol; 1987 Mar; 1(1):13-23. PubMed ID: 2972167
[TBL] [Abstract][Full Text] [Related]
9. High-dose depot-medroxyprogesterone acetate (DMPA) - effects on lipid and lipoprotein metabolism.
Crona N; Enk L; Samsioe G; Silfverstolpe G; Skryten A
Eur J Obstet Gynecol Reprod Biol; 1983 Oct; 16(2):97-105. PubMed ID: 6227506
[TBL] [Abstract][Full Text] [Related]
10. Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.
Crook D; Gardner R; Worthington M; Nolan J; Stevenson JC; Shaw RW
Horm Res; 1989; 32 Suppl 1():157-60. PubMed ID: 2533147
[TBL] [Abstract][Full Text] [Related]
11. [Plasma lipoprotein fractions in high-dose medroxyprogesterone acetate therapy in metastatic breast cancer].
Brockerhoff P; Grill HJ; Holzer A; Kreienberg R; Pollow K; Schicketanz KH; Schwarz V; Rathgen GH
Gynakol Rundsch; 1991; 31(4):189-200. PubMed ID: 1839014
[TBL] [Abstract][Full Text] [Related]
12. Management of endometriosis with oral medroxyprogesterone acetate.
Moghissi KS; Boyce CR
Obstet Gynecol; 1976 Mar; 47(3):265-7. PubMed ID: 1250555
[TBL] [Abstract][Full Text] [Related]
13. Serum lipids and lipoproteins during therapeutic amenorrhea induced by lynestrenol and depot-medroxyprogesterone acetate.
Huovinen K; Tikkanen MJ; Autio S; Härkönen T; Lommi L; Varonen S; Wilska ML
Acta Obstet Gynecol Scand; 1991; 70(4-5):349-54. PubMed ID: 1836088
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
Luciano AA; Turksoy RN; Carleo J
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):323-7. PubMed ID: 2970029
[TBL] [Abstract][Full Text] [Related]
15. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
16. Effect of large-dose progesterone on plasma levels of lipids, lipoproteins and apolipoproteins in males.
Chen JJ; Berlin FS; Margolis S
J Endocrinol Invest; 1986 Aug; 9(4):281-5. PubMed ID: 2946755
[TBL] [Abstract][Full Text] [Related]
17. Progestin reversal of ureteral endometriosis.
Gantt PA; Hunt JB; McDonough PG
Obstet Gynecol; 1981 May; 57(5):665-7. PubMed ID: 6452593
[TBL] [Abstract][Full Text] [Related]
18. Effects of high dose progestin on serum lipids and lipid metabolizing enzymes in patients with endometrial cancer.
Lehtonen A; Grönroos M; Marniemi J; Peltonen P; Mäntylä M; Niskanen J; Rautio A; Hietanen E
Horm Metab Res; 1985 Jan; 17(1):32-4. PubMed ID: 3155702
[TBL] [Abstract][Full Text] [Related]
19. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
Barnes RB; Roy S; Lobo RA
Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832
[TBL] [Abstract][Full Text] [Related]
20. [Subfractions of high density lipoproteins in relation to age].
Richter V; Rassoul F; Purcz T; Faki R
Z Gerontol; 1990; 23(1):50-5. PubMed ID: 2327147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
